Bevacizumab is contraindicated in patients who are allergic or hypersensitive to Bevacizumab or to any of the other ingredients of this medicine, in patients who are allergic or hypersensitive to Chinese hamster ovary (CHO) cell products or to other recombinant or humanized antibodies, and in pregnant women.